GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CODX · Jun 30, 2025

Co-Diagnostics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001641172-25-024029General Corporate
Capex intensity100thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

246.19% · OPTIONAL · VALID

Operating cash generation10thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-5087.37% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-93.87% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure70thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

665.78% · OPTIONAL · VALID

Gross margin70thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.gross_margin

80.29% · CORE · VALID

Operating margin20thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.operating_margin

-4946.14% · CORE · VALID

R&D intensity80thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

2877.33% · OPTIONAL · VALID

SBC intensity70thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

356.19% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History15 statesHistory building
Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20247/8 normalizedLevel 3Mar 31, 20257/8 normalizedLevel 3Jun 30, 20257/8 normalizedLevel 3Sep 30, 20257/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition

What moved in the state?

Capex Intensity Increased
Previous
182.81%
Current
246.19%
Delta
63.37%
Cash Generation Increased
Previous
-17394.06%
Current
-5087.37%
Delta
12306.70%
Growth Decreased
Previous
-89.25%
Current
-93.87%
Delta
-4.61%
Inventory Pressure Decreased
Previous
2154.68%
Current
665.78%
Delta
-1488.90%
Margin Increased
Previous
57.06%
Current
80.29%
Delta
23.23%
Profitability Increased
Previous
-17009.68%
Current
-4946.14%
Delta
12063.53%
R And D Intensity Decreased
Previous
9686.38%
Current
2877.33%
Delta
-6809.05%
Sbc Intensity Decreased
Previous
1740.81%
Current
356.19%
Delta
-1384.62%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · CODX Fundamental State →Has State · Co-Diagnostics, Inc. →Transitioned To · CODX Fundamental State →Transitioned To · CODX CAPEX_INTENSITY_INCREASED →Transitioned To · CODX CASH_GENERATION_INCREASED →Transitioned To · CODX GROWTH_DECREASED →Transitioned To · CODX INVENTORY_PRESSURE_DECREASED →Transitioned To · CODX MARGIN_INCREASED →Transitioned To · CODX PROFITABILITY_INCREASED →Transitioned To · CODX R_AND_D_INTENSITY_DECREASED →Transitioned To · CODX SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.